Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada

Speert, David P., Henry, Deborah, Vandamme, Peter, Corey, Mary and Mahenthiralingam, Eshwar ORCID: https://orcid.org/0000-0001-9014-3790 2002. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerging Infectious Diseases 8 (2) , pp. 181-187. 10.3201/eid0802.010163

Full text not available from this repository.

Abstract

The Burkholderia cepacia complex is an important group of pathogens in patients with cystic fibrosis (CF). Although evidence for patient-to-patient spread is clear, microbial factors facilitating transmission are poorly understood. To identify microbial clones with enhanced transmissibility, we evaluated B. cepacia complex isolates from patients with CF from throughout Canada. A total of 905 isolates from the B. cepacia complex were recovered from 447 patients in 8 of the 10 provinces; 369 (83%) of these patients had genomovar III and 43 (9.6%) had B. multivorans (genomovar II). Infection prevalence differed substantially by region (22% of patients in Ontario vs. 5% in Quebec). Results of typing by random amplified polymorphic DNA analysis or pulsed-field gel electrophoresis indicated that strains of B. cepacia complex from genomovar III are the most potentially transmissible and that the B. cepacia epidemic strain marker is a robust marker for transmissibility.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	National Center for Infectious Diseases
ISSN:	1080-6040
Related URLs:	http://dx.doi.org/10.3201/eid0805.C20805
Last Modified:	27 Oct 2022 09:01
URI:	https://orca.cardiff.ac.uk/id/eprint/64115

Citation Data

Cited 207 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item